JZP341
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JZP341, covering 2024-05-28 to 2024-05-28. Get the full timeline:
Most recent: Clinical Trial Update: A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors [Phase 1]